Business Development Manager, Immunoassays & Biomarkers (EMEA)

The role

This person will introduce ultra-sensitive Immunoassays to the Life Sciences and CRO markets throughout the EMEA region. They will deliver sales presentations, manage customer logistics, and provide technical support to Key Opinion Leaders.

What you will do

• Deliver sales presentations to clients to promote the value proposition of Spear Bio.
• Demonstrate understanding of Neuroscience market dynamics and technology adoption.
• Promote kit sales by providing instrument and Assay Service solutions.
• Provide a funnel to be managed by senior Business Development Managers.
• Be on-point for all customer logistics and follow up.
• Utilize existing network of scientific customers within Big Pharma, Biotech, CROs, and Academic market segments.
• Achieve a consistent track record exceeding quotas, revenue targets, and increasing market share.
• Provide technical support to Key Opinion Leaders throughout EMEA.
• Work with the internal Marketing team to drive lead generation programs.
• Work with the Custom Assay Services leader to support funnel building and provide Voice of Customer feedback.

Required qualifications

• MS or PhD in Biology, Biochemistry, Bioengineering or related field
• 6-12+ years of an established track record in technical sales or business development
• Experience presenting ultrasensitive immunoassays or neurology IVD products to customers
• Clear and pro-active communicator
• Advanced commercial sales acumen
• Ability to ask the right questions of potential customers
• Ability to clearly present technology solutions
• Ability to translate observations and customer feedback into strategy
• Comfortable providing and receiving feedback
• Ability to collaborate within a team environment
• Willingness to travel up to 30-40% for customer engagement and industry events

Benefits

• Competitive compensation
• Meaningful stock ownership
• Comprehensive benefits

About the company

Spear Bio, founded in 2021, is a well-funded and rapidly growing biotech start-up headquartered in Woburn, Massachusetts. The company uses proprietary Successive Proximity Extension Amplification Reaction (SPEAR) technology for ultra-sensitive immunoassays.